Post-conditioning anti-PUMA treatment protects mice against mice heart I/R injury.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 27160138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Worldwide disparities in cardiovascular disease: Challenges and solutions.

  2016cited by this paper
• PUMA is invovled in ischemia/reperfusion-induced apoptosis of mouse cerebral astrocytes.

  2015cited by this paper
• Reperfusion therapy for acute myocardial infarction: Concepts and controversies from inception to acceptance.

  2015cited by this paper
• Recent advances in the diagnosis and treatment of acute myocardial infarction.

  2015cited by this paper
• Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling.

  2013cited by this paper
• The natural cardioprotective particle HDL modulates connexin43 gap junction channels.

  2012cited by this paper
• Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury.

  2012cited by this paper
• Benidipine reduces ischemia reperfusion-induced systemic oxidative stress through suppression of aldosterone production in mice

  2012cited by this paper
• Puma, a critical mediator of cell death — one decade on from its discovery

  2012cited by this paper
• Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.

  2011cited by this paper
• BAY 11-7082, a nuclear factor-κB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model.

  2010cited by this paper
• Altered Hepatic Gene Expression Profiles Associated With Myocardial Ischemia

  2010cited by this paper
• PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis

  2009cited by this paper
• PUMA, a potent killer with or without p53

  2008cited by this paper
• CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.

  2007cited by this paper
• Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction

  2007cited by this paper
• PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress.

  2007cited by this paper
• Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion.

  2006cited by this paper

• BAK and BAX: Therapeutic Targets for Acute Myocardial Infarction and Myocardial Ischemia-Reperfusion Injury

  2025cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Targeting NF-κB and PUMA prevents heart injury in heart transplantation

  2017cites this paper
• Expression of p53 in myocardium following coronary microembolization in rats and its significance

  2017cites this paper